Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes

A Sveen,S Kilpinen,A Ruusulehto,R A Lothe,R I Skotheim

DOI: https://doi.org/10.1038/onc.2015.318

IF: 8.756

2015-08-24

Oncogene

Abstract:Alternative splicing is a widespread process contributing to structural transcript variation and proteome diversity. In cancer, the splicing process is commonly disrupted, resulting in both functional and non-functional end-products. Cancer-specific splicing events are known to contribute to disease progression; however, the dysregulated splicing patterns found on a genome-wide scale have until recently been less well-studied. In this review, we provide an overview of aberrant RNA splicing and its regulation in cancer. We then focus on the executors of the splicing process. Based on a comprehensive catalog of splicing factor encoding genes and analyses of available gene expression and somatic mutation data, we identify cancer-associated patterns of dysregulation. Splicing factor genes are shown to be significantly differentially expressed between cancer and corresponding normal samples, and to have reduced inter-individual expression variation in cancer. Furthermore, we identify enrichment of predicted cancer-critical genes among the splicing factors. In addition to previously described oncogenic splicing factor genes, we propose 24 novel cancer-critical splicing factors predicted from somatic mutations.

oncology,genetics & heredity,biochemistry & molecular biology,cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the mechanism of abnormal RNA splicing in cancer and its role in cancer development. Specifically, the authors focused on the following aspects:

1. **Overview of abnormal RNA splicing**: The paper first provided an overview of normal and abnormal RNA splicing, emphasizing the prevalence and importance of abnormal splicing in cancer.

2. **Expression changes and driver mutations in splicing factor genes**: By analyzing a large amount of gene expression and somatic mutation data, the authors explored the expression changes and mutation situations of splicing factor genes in cancer. They found that the expression of splicing factor genes in cancer samples was significantly different from that in normal samples, and the expression variability of these genes in cancer was reduced.

3. **Identification of cancer - related splicing patterns**: Based on a comprehensive catalogue of splicing factor genes and data analysis, the authors identified cancer - related splicing patterns. They found that splicing factor genes showed significant differential expression in cancer, and the inter - individual expression variability of these genes in cancer was decreased.

4. **Predicted key splicing factors in cancer**: In addition to the known oncogenic splicing factor genes, the authors also proposed 24 new key splicing factors in cancer, which were predicted from somatic mutations.

5. **Widespread abnormal splicing in cancer**: The authors discussed the widespread abnormal splicing phenomenon in cancer and how these abnormal splicings affect cancer development. They pointed out that most genes would be affected by abnormal splicing in cancer, but currently there is a lack of a comprehensive database to describe these abnormal splicing events.

6. **Application of RNA sequencing**: The paper also discussed the application of RNA sequencing technology in studying abnormal splicing in cancer, pointing out that RNA sequencing can provide a more unbiased view and is helpful for identifying differential splicing events between different molecular subtypes.

In summary, this paper aims to comprehensively analyze the mechanism of abnormal RNA splicing in cancer and its role in cancer development, providing an important theoretical basis for understanding the occurrence and development of cancer.